Angeles Wealth Management LLC Has $69,000 Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Angeles Wealth Management LLC lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2,083.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 524 shares of the financial services provider’s stock after buying an additional 500 shares during the period. Angeles Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $69,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of IBB. Martin Capital Advisors LLP increased its position in iShares Biotechnology ETF by 9.6% during the fourth quarter. Martin Capital Advisors LLP now owns 14,439 shares of the financial services provider’s stock worth $1,909,000 after buying an additional 1,270 shares during the last quarter. Newbridge Financial Services Group Inc. acquired a new position in iShares Biotechnology ETF during the fourth quarter worth approximately $33,000. Kestra Private Wealth Services LLC increased its position in iShares Biotechnology ETF by 25.3% during the fourth quarter. Kestra Private Wealth Services LLC now owns 6,365 shares of the financial services provider’s stock worth $842,000 after buying an additional 1,284 shares during the last quarter. Counterweight Ventures LLC increased its position in iShares Biotechnology ETF by 1.6% during the fourth quarter. Counterweight Ventures LLC now owns 8,592 shares of the financial services provider’s stock worth $1,136,000 after buying an additional 138 shares during the last quarter. Finally, Forbes J M & Co. LLP increased its position in iShares Biotechnology ETF by 0.9% during the fourth quarter. Forbes J M & Co. LLP now owns 41,262 shares of the financial services provider’s stock worth $5,455,000 after buying an additional 352 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $134.24 on Wednesday. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57. The business’s 50 day moving average price is $135.99 and its two-hundred day moving average price is $141.17.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.